Update of the telavancin in vitro activity against SA and CoNS, including isolates with decreasing susceptibility for comparator agents in European hospitals (2013)
Update of the telavancin in vitro activity against SA and CoNS, including isolates with decreasing susceptibility for comparator agents in European hospitals (2013), Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark